Current Quandaries in the Management of Congenital Portosystemic Shunts
Valérie McLin, Maurice Beghetti, Lorenzo D’Antiga, Stéphanie Franchi‐Abella, the International Registry of Congenital Porto‐Systemic Shunts (IRCPSS) – 21 March 2021
Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong – 20 March 2021 – The benefit of colonoscopy and/or polypectomy for colorectal cancer (CRC) prevention in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. We aimed to estimate the incidence rate of CRC in patients with NAFLD who had and had not undergone colonoscopy.
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah – 19 March 2021 – HCV infections have increased in recent years due to injection drug use and the opioid epidemic. Simultaneously, HCV cure has become a reality, with the advent of direct‐acting antivirals (DAAs) and expansion of treatment programs. As a result, HCV screening recommendations now include all adults, including pregnant individuals; and many countries have endorsed widespread DAA access as a strategy to achieve HCV eradication.
Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease
Joseph W. Beals, Gordon I. Smith, Mahalakshmi Shankaran, Anja Fuchs, George G. Schweitzer, Jun Yoshino, Tyler Field, Marcy Matthews, Edna Nyangau, Darya Morozov, Bettina Mittendorfer, Marc K. Hellerstein, Samuel Klein – 19 March 2021
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah – 19 March 2021 – HCV infections have increased in recent years due to injection drug use and the opioid epidemic. Simultaneously, HCV cure has become a reality, with the advent of direct‐acting antivirals (DAAs) and expansion of treatment programs. As a result, HCV screening recommendations now include all adults, including pregnant individuals; and many countries have endorsed widespread DAA access as a strategy to achieve HCV eradication.
Professional Use of Social Media by Hepatology Providers
Patricia P. Bloom, Scott Matherly, Sonal Kumar, Christopher Koh – 19 March 2021
Letter to the Editor: Balloon‐Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Rebleeding: A Paradigm Shift?
Sanchit Sharma, Deepak Gunjan, Anoop Saraya – 19 March 2021
A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV‐HIV Co‐infected Adults in North America
Richard K. Sterling, Wendy C. King, Mandana Khalili, Raymond T. Chung, Mark Sulkowski, Mamta K. Jain, Mauricio Lisker‐Melman, Marc G. Ghany, David K. Wong, Amanda S. Hinerman, Atul K. Bhan, Abdus S. Wahed, David E. Kleiner, the HBV‐HIV Cohort Study of the Hepatitis B Research Network – 19 March 2021
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Riad Salem, Guy E. Johnson, Edward Kim, Ahsun Riaz, Vivian Bishay, Eveline Boucher, Kirk Fowers, Robert Lewandowski, Siddharth A. Padia – 18 March 2021
A Possible Association Between a Nucleotide‐Binding Domain LRR‐Containing Protein Family PYD‐Containing Protein 1 Mutation and an Autoinflammatory Disease Involving Liver Cirrhosis
Hiroki Yasudo, Taiki Ando, Akie Maehara, Tomoaki Ando, Kumi Izawa, Atsushi Tanabe, Ayako Kaitani, Shigeru Nomura, Masafumi Seki, Kenichi Yoshida, Hirotsugu Oda, Yoko Okamoto, Hexing Wang, Anna Kamei, Mayuki Kojima, Meiko Kimura, Koichiro Uchida, Nobuhiro Nakano, Junichi Kaneko, Nobuyuki Ebihara, Kiyoshi Hasegawa, Toshiaki Shimizu, Junko Takita, Hideoki Ogawa, Ko Okumura, Seishi Ogawa, Naoto Tamura, Jiro Kitaura – 18 March 2021